Kin Health raises $9 million to build patient-facing AI notetaker

Kin Health has raised $9 million in a seed funding round led by Maveron to develop an AI notetaker designed for patients rather than healthcare providers. The tool is built to transcribe doctor visits and parse medical advice. The market for AI notetaking devices has grown significantly in the U.S., generating over $600 million in revenue last year, according to a Menlo Ventures report. While existing tools in this category primarily target doctors and clinics to reduce administrative burdens, Kin Health is focusing directly on the patient.

The startup was co-founded by physicians Arpan Parikh and Amit Parikh, alongside Kyle Alwyn. The founders previously built a service they sold to the health platform GoodRx, and they are using a similar business model for Kin Health. The company plans to keep the app free of cost forever, monetizing instead through referrals to services such as specialists and labs. Currently, the app only displays notes from conversations recorded during consultations. However, the company plans to bring in data from other health sources, including physicians’ own notes through electronic health record (EHR) systems, this year. Co-founder Kyle Alwyn stated that the goal is to create a health graph to store information from multiple sources, converting stored health data into a utility that patients can use to drive behavioral change.

While Kin Health emphasizes data privacy, the tool is not HIPAA-certified. Because it is a patient-facing application, it does not fall under the Health Insurance Portability and Accountability Act (HIPAA)—the U.S. standard for health data privacy—though the company states it adheres to the same privacy standards. This distinction comes as AI in healthcare is being received with a measure of caution and apprehension. Industry experts, including Dr. Rebecca Mishuris, chief health information officer and VP at Mass General Brigham, emphasize the need for careful oversight. Mishuris noted that generative AI will hallucinate due to its predictive nature, making it essential for clinicians to review any drafted notes before signing them.

Despite these industry concerns, backers see a significant distribution advantage in Kin Health’s patient-first model. Natalie Dillon, a partner at Maveron, explained that traditional provider-side tools often require patients to coordinate their own treatment actions. In contrast, Dillon stated: “Kin is built to solve an entirely different consumer need: it can travel with them between specialists, systems, and providers. It’s not beholden to any single health network or EHR relationship. It’s built to serve the patient, not the institution, and that’s a massive distribution advantage.”

Why it matters

Kin Health is positioning its AI notetaker as a patient-centric tool that travels between specialists and health networks, distinguishing it from provider-side tools that are often tied to specific EHR relationships.